Perspective Interest Expense from 2010 to 2025
| CATX Stock | 2.52 0.03 1.20% |
Interest Expense | First Reported 1999-03-31 | Previous Quarter 23 K | Current Value 69 K | Quarterly Volatility 113.5 K |
Check Perspective Therapeutics financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Perspective Therapeutics' main balance sheet or income statement drivers, such as Depreciation And Amortization of 1.2 M, Total Revenue of 1.6 M or Gross Profit of 1.3 M, as well as many indicators such as Price To Sales Ratio of 54.85, Dividend Yield of 0.0 or PTB Ratio of 1.22. Perspective financial statements analysis is a perfect complement when working with Perspective Therapeutics Valuation or Volatility modules.
Perspective | Interest Expense |
Latest Perspective Therapeutics' Interest Expense Growth Pattern
Below is the plot of the Interest Expense of Perspective Therapeutics over the last few years. It is the cost incurred by an entity for borrowed funds, including loans, bonds, or lines of credit. Perspective Therapeutics' Interest Expense historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Perspective Therapeutics' overall financial position and show how it may be relating to other accounts over time.
| Interest Expense | 10 Years Trend |
|
Interest Expense |
| Timeline |
Perspective Interest Expense Regression Statistics
| Arithmetic Mean | 70,771 | |
| Geometric Mean | 20,484 | |
| Coefficient Of Variation | 86.96 | |
| Mean Deviation | 48,929 | |
| Median | 75,600 | |
| Standard Deviation | 61,541 | |
| Sample Variance | 3.8B | |
| Range | 216.6K | |
| R-Value | 0.03 | |
| Mean Square Error | 4.1B | |
| R-Squared | 0.0007 | |
| Significance | 0.92 | |
| Slope | 349.13 | |
| Total Sum of Squares | 56.8B |
Perspective Interest Expense History
About Perspective Therapeutics Financial Statements
Perspective Therapeutics investors use historical fundamental indicators, such as Perspective Therapeutics' Interest Expense, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in Perspective Therapeutics. Please read more on our technical analysis and fundamental analysis pages.
| Last Reported | Projected for Next Year | ||
| Interest Expense | 75.6 K | 89.8 K |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.| ZLAB | Zai Lab | |
| ASLE | AerSale Corp | |
| ATS | AT S Austria |
Additional Tools for Perspective Stock Analysis
When running Perspective Therapeutics' price analysis, check to measure Perspective Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Perspective Therapeutics is operating at the current time. Most of Perspective Therapeutics' value examination focuses on studying past and present price action to predict the probability of Perspective Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Perspective Therapeutics' price. Additionally, you may evaluate how the addition of Perspective Therapeutics to your portfolios can decrease your overall portfolio volatility.